Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

Autopsy shows widespread amyloid and tau in patient who received contaminated biological m ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

Discover how AI is reshaping Alzheimer’s and dementia care through early detection, faster clinical trials, and improved ...

Vitamin D may be a potentially modifiable factor to reduce dementia risk, study suggests ...

Boosting the brain's waste-disposal system is increasingly showing promise for Alzheimer's disease, with a study now suggesting that a novel approach eases brain deficits and symptoms associated with ...

Doctors say that the number of people with Alzheimer’s disease could potentially triple within the next 25 years. Families of ...

The idea that two conditions at opposite ends of life might be biologically linked is beginning to upend long-standing ...

The origins of Alzheimer's remain contentious, but a new study suggests the disease may emerge as two key proteins compete ...

A new study suggests that a hormone therapy harvested from human corpses may be linked to a rare, controversial form of ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...